The implementation of vascular surgery and on-site endovascular aneurysm repair (EVAR) now available in at Thunder Bay Regional Health Sciences Centre is a major milestone in the establishment of a full cardiovascular surgery program for Northwestern Ontario.
Cancer cells have a natural defence against radiation therapy and chemotherapy – in fact all cells in the body have some sort of protection from harmful radiation and chemicals. One highly specialized research project happening in collaboration with several institutions in Thunder Bay may develop an innovative new way to break down those protections in cancer cells.
Boozhoo. Miigwech. A simple greeting. A few familiar words spoken in your own language. They can go a long way to make you feel more comfortable and at ease when you're away from home. That's why Thunder Bay Regional Health Sciences Centre offers Ojibwe lessons to staff and volunteers. It's part of a commitment to enhance a welcoming environment for Indigenous patients and families.
The implementation of vascular surgery and on-site endovascular aneurysm repair (EVAR) now available in Northwestern Ontario is a major milestone in the establishment of a full cardiovascular surgery program for the region.
Thunder Bay Regional Health Sciences Centre celebrated Mental Health Awareness Week, an annual national event that takes place the first week of May. People from all walks of life are encouraged to learn, talk, reflect and engage with others on all issues relating to mental health. Acute mental health is one of our Hospital’s strategic priorities, and we recognize mental health as an integral part of overall health.
Sexual assault reaches beyond those who are directly involved and affects everyone in our community. In addition to the personal costs to the physical and emotional health of the victim, there are costs to our society. Assault can affect how a person performs at school, their effectiveness at work and how they participate in the community. Assault may also affect how people are able to interact in healthy ways in their relationships and in how they are able to parent.
he cyclotron passed a major milestone in 2016, delivering its first radioactive isotope (an atomic variant of an element) fluorine-18 for research and calibration purposes. Now, an application is pending with Health Canada to produce the radiopharmaceutical fluorodeoxyglucose or FDG for patient use. Stephen Exley, Interim Director of Cyclotron Operations, emphasized that the real achievement is the homegrown cyclotron program itself.